Market Overview

Stocks Hitting 52-Week Lows

Related TLAB
Temple to Distribute Tellabs Optical LAN in EMEA Markets
Top 4 Small-Cap Stocks In The Communication Equipment Industry With The Highest Revenue Estimates
Related CLSN
Celsion Announces Potent, Durable Preclinical Lung Expression Data for Its Novel TheraSilence RNA Program
Celsion Corporation Announces ASCO 2015 GEN-1 Immunotherapy Phase 1b Results in Ovarian Cancer Presentation

Tellabs (NASDAQ: TLAB) shares dropped 7.89% to touch a new 52-week low of $2.10. Tellabs issued downbeat Q1 revenue forecast.

Celsion (NASDAQ: CLSN) shares lost 12.59% to create a new 52-week low of $1.32. Celsion shares have dropped 22.56% over the past 52 weeks, while the S&P 500 index has gained 11.39% in the same period.

Brightcove (NASDAQ: BCOV) shares touched a new 52-week low of $6.59. Brightcove issued weak Q1 outlook.

Stemline Therapeutics (NASDAQ: STML) shares touched a new 52-week low of $10.52. Stemline Therapeutics announced today the closing of its earlier announced initial public offering of 3,815,291 shares at an offering price of $10.00 a share.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets


Related Articles (CLSN + bcov)

Around the Web, We're Loving...